Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Bos

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Serous retinal detachment in preeclampsia]A M Bos, A J van Loon, J G Ameln
British Journal of Cancer|June 23, 2000
Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancerA M Bos, H de Graaf, E G de Vries, et al.
Clinical Nurse Specialist CNS|April 10, 2015
Breast self-examination education for BRCA mutation carriers by clinical nurse specialistsAnnemiek Visser, Wilmy C A M Bos, Judith B Prins, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 9, 2000
[Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control]I M Evers, A M Bos, A L Aalders, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 12, 2017
Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancerJanine T Hidding, Carien H G Beurskens, Philip J van der Wees, et al.
British Journal of Cancer|December 18, 2001
A phase I and pharmacokinetic study of intraperitoneal topotecanL S Hofstra, A M Bos, E G de Vries, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumoursA M Bos, E G de Vries, P Dombernovsky, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Serous retinal detachment in preeclampsia]A M Bos, A J van Loon, J G Ameln
British Journal of Cancer|June 23, 2000
Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancerA M Bos, H de Graaf, E G de Vries, et al.
Clinical Nurse Specialist CNS|April 10, 2015
Breast self-examination education for BRCA mutation carriers by clinical nurse specialistsAnnemiek Visser, Wilmy C A M Bos, Judith B Prins, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 9, 2000
[Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control]I M Evers, A M Bos, A L Aalders, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 12, 2017
Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancerJanine T Hidding, Carien H G Beurskens, Philip J van der Wees, et al.
British Journal of Cancer|December 18, 2001
A phase I and pharmacokinetic study of intraperitoneal topotecanL S Hofstra, A M Bos, E G de Vries, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumoursA M Bos, E G de Vries, P Dombernovsky, et al.
Pageof 1